BOSTON, MA--(Marketwired - Nov 6, 2014) - Eximo, Inc., an emerging cloud company working to fundamentally change how applications are created, delivered and consumed, today announced Robert "Bob" Hoyt ...

BOSTON, MA--(Marketwired - Feb 23, 2015) - Eximo, an emerging cloud company that allows businesses to accelerate the migration of enterprise applications to the cloud, today announced its acceptance ...

REHOVOT, Israel--(BUSINESS WIRE)--Eximo Medical has completed its Series A funding round of $1.6M. Accelmed, a leading medical device Investment Fund, led the round, with the participation of the ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...

AngioDynamics signed a $66 million deal to acquire Eximo Medical, which has been looking to commercialize its laser-based treatment for peripheral artery disease found both above and below the knee.

Eximo Medical’s B-Laser Atherectomy System treats Peripheral Artery Disease including ISR. Laser system treats Peripheral Artery Diseases including ISR. Eximo Medical, based in Rehovot, Israel, has ...

Eximo’s 355nm Laser Atherectomy system has received 510(k) clearance to treat Peripheral Artery Disease. Eximo’s laser tech is certified for the treatment of Peripheral Artery Disease (PAD).

Almost four months after reporting that it had secured an FDA nod for its B-Laser atherectomy system, Eximo Medical Ltd. has seen the launch and first commercial use of the device for treatment of ...

Angiodynamics Inc., of Latham, N.Y., is picking up Rehovot, Israel-based Eximo Medical Ltd. for $46 million up front and up to $20 million of contingent consideration related to certain technical and ...